In the animal model of no obesity diabetes, ICOS promoted the development of hyperglycemia through the increased production of IFN-γ by Th1 while sustaining the function and homeostasis of Treg cells (91, 92). The gene discussed is IFNG; the disease is Hyperglycemia.